Statistics for Collplant Biotechnologies Ltd (id:6868 CLGN)

Valuation metrics

Market cap

47.54M

Enterprise value

32.46M

Trailing P/E (ttm)

-6.58

Forward P/E

-10.64

PEG ratio

-10.64

Price/Sales (ttm)

68.99

Price/Book (mrq)

2.29

Enterprise Value/Revenue

47.11

Enterprise Value/EBITDA

-1.88

Overview

Shares outstanding

11.45M

Float

7.82M

Shares short

15.43K

% Held by insiders

0.10%

% Held by institutions

0.12%

Average volume (10 days)

24.61K

Average volume (90 days)

Price summary

52-Week low

3.31

52-Week high

6.99

52-Week change

-36.14%

Beta

0.48

50-Day moving average

4.44

200-Day moving average

5.06

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

November 21th, 2016

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

81.83%

Operating margin

-1,769.48%

Operational effectiveness

Return on assets

-33.77%

Return on equity

-61.55%

Income statement

Revenue (ttm)

0.06

Revenue per share (ttm)

0.06

Quarterly revenue growth (yoy)

Gross profit (ttm)

8.97M

EBITDA

-17,308,000.00

Net income to common (ttm)

-17,471,000.00

Diluted EPS (ttm)

-1.53

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

18.92M

Total cash per share (mrq)

1.65

Total debt (mrq)

3.38M

Total Debt/Equity (mrq)

16.33

Current ratio (mrq)

627.40%

Book value per share (mrq)

1.81

Cash flow

Cash flow statement

-2,750,000.00

Levered free cash flow (LFCF)

2.13M